Moderador: Dr. Felix Jose Alvarez Ramires | |
Palestrante: Dra. Maria Cristina de Oliveira Izar | |
Palestrante: Dra. Livia Maria Garcia Melro | |
Palestrante: Dr. Miguel Antonio Moretti | |
Palestrante: Dr. José Francisco Kerr Saraiva | |
Palestrante: Dr. Dirceu Rodrigues de Almeida | |
Palestrante: Dr. Vagner Madrini Junior |
19h00 | TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial |
19h10 | ECMO-CS – Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Primary Results from the Multicenter, Randomized ECMO-CS Trial |
19h20 | PROMINENT – A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of Cardiovascular Disease |
19h30 | EMPA-KIDNEY – Empagliflozin and Cardiovascular Outcomes in Patients with Chronic Kidney Disease: The EMPA-KIDNEY Trial |
19h40 | PRECISE – Comparison of a Precision Care Strategy with Usual Testing to Guide Management of Stable Patients with Suspected Coronary Artery Disease: The Precise Randomized Trial |
19h50 | DCP – Chlorthalidone Compared to Hydrochlorothiazide for the Prevention of Cardiovascular Events in Patients with Hypertension |
20h00 | Discussão/Perguntas |
20h30 | Encerramento |